By Jen McFarland, WRAL TechWire
DURHAM — Just a year after their Series A financing round of $24.5 million, Durham-based Elo Life Systems has shared the announcement of an oversubscribed Series A2.
Like last year’s funding, this round is equity-based and involves 14 investors, according to the initial SEC filing. The company has also provided a press release announcing $20.5 million raised in this round, with financing led by DCVC Bio and Novo Holdings, both of which also participated in the Series A financing. The SEC filing leaves open funding up to $25 million.Read more